These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 36297471)

  • 21. Real-time monitoring of in vivo acute necrotic cancer cell death induced by near infrared photoimmunotherapy using fluorescence lifetime imaging.
    Nakajima T; Sano K; Mitsunaga M; Choyke PL; Kobayashi H
    Cancer Res; 2012 Sep; 72(18):4622-8. PubMed ID: 22800710
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The feasibility of Miltuximab®-IRDye700DX-mediated photoimmunotherapy of solid tumors.
    Polikarpov DM; Campbell DH; Lund ME; Lu Y; Lu Y; Wu J; Walsh BJ; Zvyagin AV; Gillatt DA
    Photodiagnosis Photodyn Ther; 2020 Dec; 32():102064. PubMed ID: 33069874
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Near Infrared Photoimmunotherapy; A Review of Targets for Cancer Therapy.
    Kato T; Wakiyama H; Furusawa A; Choyke PL; Kobayashi H
    Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34064074
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Near-Infrared Photoimmunotherapy (NIR-PIT) in Urologic Cancers.
    Fukushima H; Turkbey B; Pinto PA; Furusawa A; Choyke PL; Kobayashi H
    Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740662
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Photoimmunotherapy: comparative effectiveness of two monoclonal antibodies targeting the epidermal growth factor receptor.
    Sato K; Watanabe R; Hanaoka H; Harada T; Nakajima T; Kim I; Paik CH; Choyke PL; Kobayashi H
    Mol Oncol; 2014 May; 8(3):620-32. PubMed ID: 24508062
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Near infrared photoimmunotherapy of cancer; possible clinical applications.
    Wakiyama H; Kato T; Furusawa A; Choyke PL; Kobayashi H
    Nanophotonics; 2021 Sep; 10(12):3135-3151. PubMed ID: 36405499
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD47-Targeted Near-Infrared Photoimmunotherapy for Human Bladder Cancer.
    Kiss B; van den Berg NS; Ertsey R; McKenna K; Mach KE; Zhang CA; Volkmer JP; Weissman IL; Rosenthal EL; Liao JC
    Clin Cancer Res; 2019 Jun; 25(12):3561-3571. PubMed ID: 30890547
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeted Phototherapy for Malignant Pleural Mesothelioma: Near-Infrared Photoimmunotherapy Targeting Podoplanin.
    Nishinaga Y; Sato K; Yasui H; Taki S; Takahashi K; Shimizu M; Endo R; Koike C; Kuramoto N; Nakamura S; Fukui T; Yukawa H; Baba Y; K Kaneko M; Chen-Yoshikawa TF; Kobayashi H; Kato Y; Hasegawa Y
    Cells; 2020 Apr; 9(4):. PubMed ID: 32326079
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Near infrared photoimmunotherapy with avelumab, an anti-programmed death-ligand 1 (PD-L1) antibody.
    Nagaya T; Nakamura Y; Sato K; Harada T; Choyke PL; Hodge JW; Schlom J; Kobayashi H
    Oncotarget; 2017 Jan; 8(5):8807-8817. PubMed ID: 27716622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Near-infrared photoimmunotherapy of cancer: a new approach that kills cancer cells and enhances anti-cancer host immunity.
    Kobayashi H; Furusawa A; Rosenberg A; Choyke PL
    Int Immunol; 2021 Jan; 33(1):7-15. PubMed ID: 32496557
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin-15 after Near-Infrared Photoimmunotherapy (NIR-PIT) Enhances T Cell Response against Syngeneic Mouse Tumors.
    Maruoka Y; Furusawa A; Okada R; Inagaki F; Wakiyama H; Kato T; Nagaya T; Choyke PL; Kobayashi H
    Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32927646
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibody Drug Conjugates of Near-Infrared Photoimmunotherapy (NIR-PIT) in Breast Cancers.
    Cui Y; Xu Y; Li Y; Sun Y; Hu J; Jia J; Li X
    Technol Cancer Res Treat; 2023; 22():15330338221145992. PubMed ID: 36734039
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Near-infrared photoimmunotherapy (NIR-PIT) on cholangiocarcinoma using a novel catheter device with light emitting diodes.
    Hirata H; Kuwatani M; Nakajima K; Kodama Y; Yoshikawa Y; Ogawa M; Sakamoto N
    Cancer Sci; 2021 Feb; 112(2):828-838. PubMed ID: 33345417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined CD44- and CD25-Targeted Near-Infrared Photoimmunotherapy Selectively Kills Cancer and Regulatory T Cells in Syngeneic Mouse Cancer Models.
    Maruoka Y; Furusawa A; Okada R; Inagaki F; Fujimura D; Wakiyama H; Kato T; Nagaya T; Choyke PL; Kobayashi H
    Cancer Immunol Res; 2020 Mar; 8(3):345-355. PubMed ID: 31953245
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Opening up new VISTAs: V-domain immunoglobulin suppressor of T cell activation (VISTA) targeted near-infrared photoimmunotherapy (NIR-PIT) for enhancing host immunity against cancers.
    Wakiyama H; Furusawa A; Okada R; Inagaki F; Kato T; Furumoto H; Fukushima H; Okuyama S; Choyke PL; Kobayashi H
    Cancer Immunol Immunother; 2022 Dec; 71(12):2869-2879. PubMed ID: 35445836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Near infrared photoimmunotherapy targeting bladder cancer with a canine anti-epidermal growth factor receptor (EGFR) antibody.
    Nagaya T; Okuyama S; Ogata F; Maruoka Y; Knapp DW; Karagiannis SN; Fazekas-Singer J; Choyke PL; LeBlanc AK; Jensen-Jarolim E; Kobayashi H
    Oncotarget; 2018 Apr; 9(27):19026-19038. PubMed ID: 29721181
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of low-molecular-weight ligand and whole antibody in prostate-specific membrane antigen targeted near-infrared photoimmunotherapy.
    Nakajima K; Miyazaki F; Terada K; Takakura H; Suzuki M; Ogawa M
    Int J Pharm; 2021 Nov; 609():121135. PubMed ID: 34571072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Near-infrared photoimmunotherapy of pancreatic cancer using an indocyanine green-labeled anti-tissue factor antibody.
    Aung W; Tsuji AB; Sugyo A; Takashima H; Yasunaga M; Matsumura Y; Higashi T
    World J Gastroenterol; 2018 Dec; 24(48):5491-5504. PubMed ID: 30622378
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidermal Growth Factor Receptor (EGFR)-targeted Photoimmunotherapy (PIT) for the Treatment of EGFR-expressing Bladder Cancer.
    Railkar R; Krane LS; Li QQ; Sanford T; Siddiqui MR; Haines D; Vourganti S; Brancato SJ; Choyke PL; Kobayashi H; Agarwal PK
    Mol Cancer Ther; 2017 Oct; 16(10):2201-2214. PubMed ID: 28619755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular targeted photoimmunotherapy for HER2-positive human gastric cancer in combination with chemotherapy results in improved treatment outcomes through different cytotoxic mechanisms.
    Ito K; Mitsunaga M; Arihiro S; Saruta M; Matsuoka M; Kobayashi H; Tajiri H
    BMC Cancer; 2016 Jan; 16():37. PubMed ID: 26810644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.